• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法国卫生产品使用和护理轨迹间接健康数据关联的开发:系统评价。

Development of Indirect Health Data Linkage on Health Product Use and Care Trajectories in France: Systematic Review.

机构信息

Hospices Civils de Lyon, Groupement Hospitalier Sud, Unité de pharmacie clinique oncologique, Pierre-Bénite, France.

Translational Innovation in Medicine and Complexity - Unité Mixte de Recherche 5525, Université Grenoble Alpes, Grenoble, France.

出版信息

J Med Internet Res. 2023 May 18;25:e41048. doi: 10.2196/41048.

DOI:10.2196/41048
PMID:37200084
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10236279/
Abstract

BACKGROUND

European national disparities in the integration of data linkage (ie, being able to match patient data between databases) into routine public health activities were recently highlighted. In France, the claims database covers almost the whole population from birth to death, offering a great research potential for data linkage. As the use of a common unique identifier to directly link personal data is often limited, linkage with a set of indirect key identifiers has been developed, which is associated with the linkage quality challenge to minimize errors in linked data.

OBJECTIVE

The aim of this systematic review is to analyze the type and quality of research publications on indirect data linkage on health product use and care trajectories in France.

METHODS

A comprehensive search for all papers published in PubMed/Medline and Embase databases up to December 31, 2022, involving linked French database focusing on health products use or care trajectories was realized. Only studies based on the use of indirect identifiers were included (ie, without a unique personal identifier available to easily link the databases). A descriptive analysis of data linkage with quality indicators and adherence to the Bohensky framework for evaluating data linkage studies was also realized.

RESULTS

In total, 16 papers were selected. Data linkage was performed at the national level in 7 (43.8%) cases or at the local level in 9 (56.2%) studies. The number of patients included in the different databases and resulting from data linkage varied greatly, respectively, from 713 to 75,000 patients and from 210 to 31,000 linked patients. The diseases studied were mainly chronic diseases and infections. The objectives of the data linkage were multiple: to estimate the risk of adverse drug reactions (ADRs; n=6, 37.5%), to reconstruct the patient's care trajectory (n=5, 31.3%), to describe therapeutic uses (n=2, 12.5%), to evaluate the benefits of treatments (n=2, 12.5%), and to evaluate treatment adherence (n=1, 6.3%). Registries are the most frequently linked databases with French claims data. No studies have looked at linking with a hospital data warehouse, a clinical trial database, or patient self-reported databases. The linkage approach was deterministic in 7 (43.8%) studies, probabilistic in 4 (25.0%) studies, and not specified in 5 (31.3%) studies. The linkage rate was mainly from 80% to 90% (reported in 11/15, 73.3%, studies). Adherence to the Bohensky framework for evaluating data linkage studies showed that the description of the source databases for the linkage was always performed but that the completion rate and accuracy of the variables to be linked were not systematically described.

CONCLUSIONS

This review highlights the growing interest in health data linkage in France. Nevertheless, regulatory, technical, and human constraints remain major obstacles to their deployment. The volume, variety, and validity of the data represent a real challenge, and advanced expertise and skills in statistical analysis and artificial intelligence are required to treat these big data.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b387/10236279/570e12e5d308/jmir_v25i1e41048_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b387/10236279/1c3ade4b7fdf/jmir_v25i1e41048_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b387/10236279/570e12e5d308/jmir_v25i1e41048_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b387/10236279/1c3ade4b7fdf/jmir_v25i1e41048_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b387/10236279/570e12e5d308/jmir_v25i1e41048_fig2.jpg
摘要

背景

最近强调了欧洲各国在将数据链接(即能够在数据库之间匹配患者数据)纳入常规公共卫生活动方面存在差异。在法国,索赔数据库涵盖了从出生到死亡的几乎所有人,为数据链接提供了巨大的研究潜力。由于通常限制使用通用唯一标识符直接链接个人数据,因此已开发出使用一组间接关键标识符进行链接的方法,这与最小化链接数据错误的链接质量挑战有关。

目的

本系统评价的目的是分析法国关于健康产品使用和护理轨迹的间接数据链接的研究出版物的类型和质量。

方法

对截至 2022 年 12 月 31 日在 PubMed/Medline 和 Embase 数据库中发表的所有论文进行了全面搜索,涉及到关注健康产品使用或护理轨迹的法国链接数据库。仅包括基于使用间接标识符的研究(即,没有可用的唯一个人标识符来轻松链接数据库)。还对数据链接进行了描述性分析,并使用 Bohensky 框架评估了数据链接研究的质量指标和遵守情况。

结果

共选择了 16 篇论文。7 项(43.8%)在国家层面进行了数据链接,9 项(56.2%)在地方层面进行了数据链接。不同数据库中包含的患者数量和由此产生的链接患者数量差异很大,分别为 713 至 75,000 名患者和 210 至 31,000 名链接患者。研究的疾病主要是慢性病和传染病。数据链接的目标多种多样:估计不良反应(ADR;n=6,37.5%)、重建患者的护理轨迹(n=5,31.3%)、描述治疗用途(n=2,12.5%)、评估治疗益处(n=2,12.5%)和评估治疗依从性(n=1,6.3%)。登记处是与法国索赔数据链接最频繁的数据库。没有研究关注与医院数据仓库、临床试验数据库或患者自我报告数据库的链接。链接方法在 7 项研究中是确定性的(43.8%),在 4 项研究中是概率性的(25.0%),在 5 项研究中没有指定(31.3%)。链接率主要在 80%到 90%之间(15 项研究中的 11 项,73.3%)。对评估数据链接研究的 Bohensky 框架的遵守情况表明,始终对链接的源数据库进行了描述,但没有系统地描述要链接的变量的完成率和准确性。

结论

本综述强调了法国对健康数据链接的兴趣日益浓厚。然而,监管、技术和人力资源方面的限制仍然是其部署的主要障碍。数据的数量、种类和有效性是一个真正的挑战,需要在统计分析和人工智能方面具备先进的专业知识和技能来处理这些大数据。

相似文献

1
Development of Indirect Health Data Linkage on Health Product Use and Care Trajectories in France: Systematic Review.法国卫生产品使用和护理轨迹间接健康数据关联的开发:系统评价。
J Med Internet Res. 2023 May 18;25:e41048. doi: 10.2196/41048.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
5
Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.医疗专业人员在急症医院环境中团队合作教育的经验:对定性文献的系统综述
JBI Database System Rev Implement Rep. 2016 Apr;14(4):96-137. doi: 10.11124/JBISRIR-2016-1843.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
7
What is the value of routinely testing full blood count, electrolytes and urea, and pulmonary function tests before elective surgery in patients with no apparent clinical indication and in subgroups of patients with common comorbidities: a systematic review of the clinical and cost-effective literature.在没有明显临床指征的患者和常见合并症患者亚组中,在择期手术前常规检测全血细胞计数、电解质和尿素以及肺功能测试的价值:对临床和成本效益文献的系统评价。
Health Technol Assess. 2012 Dec;16(50):i-xvi, 1-159. doi: 10.3310/hta16500.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
9
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.
10
The measurement and monitoring of surgical adverse events.手术不良事件的测量与监测
Health Technol Assess. 2001;5(22):1-194. doi: 10.3310/hta5220.

引用本文的文献

1
Creation of a Laboratory for Statistics and Analysis of Dependence and Chronic Conditions: Protocol for the Bages Territorial Specialization and Competitiveness Project (PECT BAGESS).创建一个成瘾与慢性病统计分析实验室:巴热斯地区专业化与竞争力项目(PECT BAGESS)方案
JMIR Res Protoc. 2023 Jul 26;12:e46542. doi: 10.2196/46542.

本文引用的文献

1
[Linking Interventional Cardiology clinical registry data with French hospital administrative data: Development and validation of deterministic record linkage].[将介入心脏病学临床登记数据与法国医院管理数据相链接:确定性记录链接的开发与验证]
Rev Epidemiol Sante Publique. 2021 Apr;69(2):78-87. doi: 10.1016/j.respe.2021.01.008. Epub 2021 Mar 9.
2
Predialysis Care Trajectories of Patients With ESKD Starting Dialysis in Emergency in France.法国急诊开始透析的终末期肾病患者透析前护理轨迹
Kidney Int Rep. 2020 Oct 31;6(1):156-167. doi: 10.1016/j.ekir.2020.10.026. eCollection 2021 Jan.
3
[Health Data Hub in France, use cases in oncology and radiation oncology].
[法国健康数据中心,肿瘤学和放射肿瘤学中的用例]
Cancer Radiother. 2020 Oct;24(6-7):762-767. doi: 10.1016/j.canrad.2020.07.003. Epub 2020 Aug 29.
4
Major bleeding risk and mortality associated with antiplatelet drugs in real-world clinical practice. A prospective cohort study.抗血小板药物在真实临床实践中的大出血风险和死亡率。一项前瞻性队列研究。
PLoS One. 2020 Aug 7;15(8):e0237022. doi: 10.1371/journal.pone.0237022. eCollection 2020.
5
Overview of French databases available for studying anticancer drugs in real-life setting.概述了可用于研究真实环境中抗癌药物的法国数据库。
Fundam Clin Pharmacol. 2021 Feb;35(1):76-85. doi: 10.1111/fcp.12592. Epub 2020 Aug 17.
6
Successful linkage of French large-scale national registry populations to national reimbursement data: Improved data completeness and minimized loss to follow-up.成功将法国大规模国家注册人群与国家报销数据进行链接:提高了数据完整性并最大限度地减少了随访损失。
Arch Cardiovasc Dis. 2020 Aug-Sep;113(8-9):534-541. doi: 10.1016/j.acvd.2020.04.006. Epub 2020 Jul 22.
7
Impact Analysis of the Policy for Access of Administrative Data in France: A Before-After Study.法国行政数据获取政策的影响分析:一项前后对比研究。
Stud Health Technol Inform. 2020 Jun 16;270:1133-1137. doi: 10.3233/SHTI200339.
8
Cohort Creation and Visualization Using Graph Model in the PREDIMED Health Data Warehouse.在PREDIMED健康数据仓库中使用图模型进行队列创建和可视化。
Stud Health Technol Inform. 2020 Jun 16;270:108-112. doi: 10.3233/SHTI200132.
9
Innovative use of data sources: a cross-sectional study of data linkage and artificial intelligence practices across European countries.数据源的创新应用:一项关于欧洲国家数据链接与人工智能实践的横断面研究。
Arch Public Health. 2020 Jun 10;78:55. doi: 10.1186/s13690-020-00436-9. eCollection 2020.
10
Existing Data Sources for Clinical Epidemiology: The PHARMO Database Network.临床流行病学的现有数据来源:PHARMO数据库网络。
Clin Epidemiol. 2020 Apr 29;12:415-422. doi: 10.2147/CLEP.S247575. eCollection 2020.